align technology inc (ALGN:NASDAQ GS)

Executive Profile*

Background*

Mr. George J. Morrow, Greg has been Vice President and General Manager of Invisalign Business of Align Technology Inc. since December 2012. Mr. Morrow has been a Consultant of Amgen Inc., since February 1, 2011. Mr. Morrow has more than 30 years of leadership experience in worldwide commercial operations. He served as an Executive Vice President of Amgen Inc. from May 2010 to January 31, 2011. He served as an Executive Vice President of Global Commercial Operations of ... Amgen Inc., from April 2003 to January 2011 and was responsible for leading all commercial activities in over 50 countries and helped launch multiple products into competitive markets. Mr. Morrow served as an Executive Vice President of Worldwide Sales and Marketing of Amgen Inc., from January 2001 to 2003. Before joining Amgen, he had over 20 years of commercial experience at Glaxo Wellcome Inc. From January 1999 to December 2000, Mr. Morrow served as President and Chief Executive Officer of Glaxo Wellcome Inc. (“Glaxo”), a subsidiary of GlaxoSmithKline plc. From January 1997 to December 1998, Mr. Morrow served as Managing Director of Glaxo Wellcome U.K., also a subsidiary of GlaxoSmithKline plc. From 1992 to 2001, Mr. Morrow held multiple leadership positions at GlaxoSmithKline Inc. From May 1993 to December 1996, Mr. Morrow served as Group Vice President for Commercial Operations of Glaxo Inc. His prior experience at Merck, from 1982 to 1992, included sales and marketing positions culminating as Vice President of Marketing. He has been a Member of Advisory Board at PBS Biotech Inc. since January 09, 2012. He has been Director of Vical Incorporated since October 2012. Mr. Morrow has been a Director of Align Technology Inc., since February 23, 2006. He serves as a Member of Health Advisory Board of Johns Hopkins Bloomberg School of Public Health. He served as a Director of CCB Financial Corp. and its subsidiary, Central Carolina Bank since 1996. He served as a Director of GlaxoSmithKline PLC and GlaxoWellcome Inc. He served as a Director of Human Genome Sciences Inc. since March 14, 2011 until August 2012. He served as a Director of Johns Hopkins Bloomberg School of Public Health. He is a Member of the Duke University Fuqua School of Business Advisory Board and Medical Center Board of Visitors. Mr. Morrow holds a B.S. in Chemistry from Southampton College, Long Island University, an M.S. in Biochemistry from Bryn Mawr College and an M.B.A. from Duke University.

Report Data Issue

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Recently Viewed
ALGN:US	$36.98 USD	-0.32

COMPETITOR COMPENSATION